Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael Sun
R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis
PLoS ONE
Multidisciplinary
Prostate-Specific Membrane Antigen Based Antibody-Drug Conjugates for Metastatic Castration-Resistance Prostate Cancer
Cureus
Related publications
Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Efficacy of and Resistance to Anti-Igf-1r Therapies in Ewing's Sarcoma Is Dependent on Insulin Receptor Signaling
Oncogene
Cancer Research
Genetics
Molecular Biology
Picropodophyllin Inhibits the Growth of Ewing's Sarcoma Cells Through the Insulin-Like Growth Factor-1 Receptor/Akt Signaling Pathway
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Microarray Analysis of Insulin and Insulin-Like Growth Factor-1 (IGF-1) Receptor Signaling Reveals the Selective Up-Regulation of the Mitogen Heparin-Binding EGF-like Growth Factor by IGF-1
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Anti-Tumor Effect of the Insulin-Like Growth Factor-1 Receptor (IGF-1R) on Human Pancreatic Cancer Cells in Both in Vitro and in Vivo Studies
Suizo
Serum Insulin Like Growth Factor (IGF-1) and Leptin Levels in Osteosarcoma
American Journal of Biochemistry and Molecular Biology
Biochemistry
Genetics
Molecular Biology
Alcohol Withdrawal Induced Change in Lipoprotein(a) : Association With the Growth Hormone/Insulin-Like Growth Factor-I (IGF-I)/IGF-Binding Protein-1 (IGFBP-1) Axis
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Phase I Study of the Anti Insulin-Like Growth Factor 1 Receptor (IGF-1R) Monoclonal Antibody, AVE1642, as Single Agent and in Combination With Bortezomib in Patients With Relapsed Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Insulin-Like Growth Factor-2 (IGF-2)
Science-Business eXchange
